NCT01681784

Brief Summary

To determine the sensitivity and specificity of urinary NGF, PGE2, IL-6, EGF or combinations in diagnosing different urodynamic diagnoses.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 10, 2012

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

September 10, 2012

Status Verified

March 1, 2009

Enrollment Period

5 years

First QC Date

September 5, 2012

Last Update Submit

September 7, 2012

Conditions

Disorder of the Lower Urinary Tract

Keywords

lower urinary tract symptomsbiomarkersurodynamic studies

Eligibility Criteria

Age20 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female patients with lower urinary tract symptoms and underwent urodynamic studies

You may qualify if:

  • Female patients with lower urinary tract symptoms

You may not qualify if:

  • acute cystitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taipei, 100, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Patients' voided urine

MeSH Terms

Conditions

Lower Urinary Tract Symptoms

Condition Hierarchy (Ancestors)

Urological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Ho-Hsiung Lin, MD, PhD

CONTACT

+88623123456hhlin@ntuh.gov.tw

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Ho-Hsiung Lin

Study Record Dates

First Submitted

September 5, 2012

First Posted

September 10, 2012

Study Start

January 1, 2009

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

September 10, 2012

Record last verified: 2009-03

Locations

TW(1)